Skip to main content
. 2018 Jul 5;61(3):388–397. doi: 10.1007/s12020-018-1665-6

Table 2.

Changes between baseline and follow-up in in the intervention and the placebo group

Vitamin D Placebo Vitamin D vs. Placebo
Baseline Follow up Changea Baseline Follow up Changea
n Mean (SD) n Mean (SD) Mean (SD) n Mean (SD) n Mean (SD) Mean (SD) Mean differenceb (95% CI) p-value
25(OH)D (nmol/L) 19 44.3 (8.3) 19 70.5 (16.2) 26.3 (14.7) 19 44.2 (7.1) 19 49.8 (21.5) 5.6 (20.2) 20.7 (9.1 to 32.3) <0.001
Weight (kg) 19 102.8 (19.4) 19 102.1 (18.9) −0.8 (2.2) 19 100.5 (13.0) 19 99.2 (13.7) −1.3 (3.1) 0.6 (−1.2 to 2.3) 0.53
BMI (kg/m2) 19 31.5 (5.4) 19 31.3 (5.2) −0.2 (0.6) 19 31.2 (3.9) 19 30.7 (3.8) −0.5 (0.9) 0.3 (−0.2 to 0.8) 0.26
Percentage body fat (%-units) 19 29.7 (6.2) 19 30.3 (7.5) 0.6 (2.0) 19 28.4 (6.4) 19 28.5 (6.2) 0.1 (2.6) 0.5 (−1.1 to 2.0) 0.54
Maximum VO2 (L/min) 17 3.02 (0.53) 17 3.04 (0.61) 0.02 (0.23) 18 3.03 (0.59) 18 3.06 (0.71) 0.03 (0.24) −0.01 (−0.2 to 0.2) 0.90
Maximum VO2/kg (ml/min/kg) 17 30.0 (6.4) 17 30.4 (7.8) 0.4 (2.5) 18 31.1 (7.8) 18 31.7 (8.7) 0.6 (2.4) −0.2 (−1.9 to 1.5) 0.80
Maximum load (Watt) 17 242.8 (52.3) 17 246.0 (54.8) 3.2 (19.0) 18 248.7 (58.9) 18 252.7 (56.3) 4.0 (11.7) −0.8 (-11.5 to 10.0) 0.89
Maximum heart rate (bpm) 17 167.6 (15.8) 17 164.3 (18.3) −3.4 (11.7) 18 162.5 (17.7) 18 164.2 (19.2) 1.7 (7.9) −5.1 (−11.9 to 1.8) 0.14
VO2 at AT (L/min) 16 1.66 (0.41) 16 1.79 (0.49) 0.13 (0.26) 17 1.78 (0.39) 17 1.78 (0.45) 0.0 (0.27) 0.13 (−0.05 to 0.33) 0.14
Reported change in physical activity Vitamin D n = 12 Placebo n = 14 0.02c
Less activity post, n (%) 0 (0%) 6 (43%)
No change, n (%) 8 (67%) 7 (50%)
More activity post, n (%) 4 (33%) 1 (7%)

aChange = Follow up minus Baseline

bBetween group differences were compared using a two-sample t-test

cChi-2 test was used for the variable “reported change in physical activity”